Influence of CuO/MgO ratio on the gene expression, cytocompatibilty, and antibacterial/anticancerous/analgesic drug loading kinetics for (15‐x) CuO‐xMgO‐10P2O5‐60SiO2‐10CaO‐5ZnO (2.5 ≤ x ≤ 12.5) mesoporous bioactive glasses
Source abstract
Abstract
Abstract In the present study, novel mesoporous bioactive glasses (MBGs) (15‐x)CuO‐xMgO‐10P2O5‐60SiO2‐10CaO‐5ZnO (2.5 ≤ x ≤ 12.5, varying in steps of 2) are synthesized using the sol‐gel technique. The structural phases of the glasses/glass ceramics were studied by XRD. The pH variation and simulated body fluids (SBF) studies demonstrated the in‐vitro bioactivity of all the MBGs. MBGs possess surface area variation between 98.22 and 442.41 cm2/g. The pore size of MBGs lies in the range of 5.8–8.8 nm. The cytotoxicity assays were conducted for MG63 human osteosarcoma cell line depicting non‐toxic behavior of all MBGs at 7.8125 μg/ml. In addition to this, the effect of the magnesium on the gene expression was also investigated using reverse transcription–polymerase chain reaction (RT‐qPCR). The MBGs were loaded with the antibacterial (vancomycin/amoxicillin), anticancerous (doxorubicin), and analgesic (Iburofen) drugs. Ibuprofen and amoxicillin drugs were almost fully loaded in all the MBGs, whereas doxorubicin and vancomycin drugs illustrated variation in loading with decreasing copper content. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 2116‐2130, 2018.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Layered Double Hydroxides Synthesis and Applications · Orthopaedic implants and arthroplasty
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Physics and Materials Science Thapar University Patiala 147004 India
Funding
University Grant Commission (UGC)
References (50)
Show source-provided references
1. 10.1007/978-3-319-56059-510.1007/978-3-319-56059-5 ↗
2. 10.1007/978-3-319-45716-110.1007/978-3-319-45716-1 ↗
3. 10.1002/1521-4095(200106)13:11<837::AID-ADMA837>3.0.CO;2-D10.1002/1521-4095(200106)13:11<837::AID-ADMA837>3.0.CO;2-D ↗
4. 10.1056/NEJMra03541510.1056/NEJMra035415 ↗
5. 10.1002/anie.20060448810.1002/anie.200604488 ↗
6. 10.1002/1097-0142(19860715)58:2 <573::AID-CNCR2820581328>3.0.CO;2-C10.1002/1097-0142(19860715)58:2 <573::AID-CNCR2820581328>3.0.CO;2-C ↗
7. 10.1016/j.jconrel.2005.11.00210.1016/j.jconrel.2005.11.002 ↗
8. 10.1002/jbm.b.3344310.1002/jbm.b.33443 ↗
9. 10.1002/jbm.a.3469010.1002/jbm.a.34690 ↗
10. 10.1021/cm801649z10.1021/cm801649z ↗
11. 10.1016/j.jconrel.2006.01.02110.1016/j.jconrel.2006.01.021 ↗
12. 10.1016/S0142-9612(03)00038-310.1016/S0142-9612(03)00038-3 ↗
13. 10.1002/mabi.20040002610.1002/mabi.200400026 ↗
14. 10.1016/j.msec.2012.05.03410.1016/j.msec.2012.05.034 ↗
15. 10.1098/rsta.2011.025810.1098/rsta.2011.0258 ↗
16. 10.1098/rsif.2009.037910.1098/rsif.2009.0379 ↗
17. 10.1007/s10856-017-5901-z10.1007/s10856-017-5901-z ↗
18. 10.1016/j.jmbbm.2014.08.00710.1016/j.jmbbm.2014.08.007 ↗
19. 10.1002/anie.20046059810.1002/anie.200460598 ↗
20. 10.1098/rsfs.2011.012110.1098/rsfs.2011.0121 ↗
21. 10.1039/C6RA06829D10.1039/C6RA06829D ↗
22. 10.1021/cm001155910.1021/cm0011559 ↗
23. 10.1007/s10856-016-5827-x10.1007/s10856-016-5827-x ↗
24. 10.1016/j.biomaterials.2006.01.01710.1016/j.biomaterials.2006.01.017 ↗
25. 10.1007/s10856-009-3732-210.1007/s10856-009-3732-2 ↗
26. 10.1126/science.109583310.1126/science.1095833 ↗
27. Controlled bioactivity in zinc‐doped sol‐gel‐derived binary bioactive glasses
28. 10.1016/j.actbio.2010.02.01210.1016/j.actbio.2010.02.012 ↗
29. 10.1007/s10856-013-4960-z10.1007/s10856-013-4960-z ↗
30. 10.1016/j.actbio.2012.06.02310.1016/j.actbio.2012.06.023 ↗
31. 10.1007/s10853-016-0563-710.1007/s10853-016-0563-7 ↗
32. Functionalized mesoporous bioactive glass scaffolds for enhanced bone tissue regeneration
33. 10.1016/j.jnoncrysol.2005.08.02410.1016/j.jnoncrysol.2005.08.024 ↗
34. 10.1002/jbm.b.1007110.1002/jbm.b.10071 ↗
35. 10.1111/j.1753-4887.2001.tb07017.x10.1111/j.1753-4887.2001.tb07017.x ↗
36. 10.1021/cm00013a03910.1021/cm00013a039 ↗
37. Zinc: an overview
38. 10.1111/j.1365-2710.1992.tb01265.x10.1111/j.1365-2710.1992.tb01265.x ↗
39. 10.1142/202810.1142/2028 ↗
40. 10.1016/j.jeurceramsoc.2008.08.00210.1016/j.jeurceramsoc.2008.08.002 ↗
41. 10.1007/s10856-006-0435-910.1007/s10856-006-0435-9 ↗
42. 10.1016/j.actbio.2011.03.01610.1016/j.actbio.2011.03.016 ↗
43. 10.1016/0022-1759(93)90092-L10.1016/0022-1759(93)90092-L ↗
44. 10.1007/BF0093268010.1007/BF00932680 ↗
45. 10.1088/1748-6041/6/3/03500610.1088/1748-6041/6/3/035006 ↗
46. 10.1038/srep0439210.1038/srep04392 ↗
47. 10.1088/1748-605X/aa766410.1088/1748-605X/aa7664 ↗
48. 10.1039/c3tb20275e10.1039/c3tb20275e ↗
49. 10.1016/j.cej.2007.07.09410.1016/j.cej.2007.07.094 ↗
50. 10.1155/2013/19813710.1155/2013/198137 ↗